Search results
Showing 151 to 200 of 1371 results for patients and public
This guideline covers rehabilitation strategies for adults who have experienced a critical illness and stayed in critical care. It aims to improve physical, psychological and cognitive outcomes in people who have been discharged from critical care.
rapid assessment of flu product zanamivir. First public board meeting Register to attend a public board meeting . 2000...
In development [GID-TA11355] Expected publication date: 09 July 2024
In development [GID-TA11186] Expected publication date: TBC
This guide describes the interim methods and process changes that NICE has implemented as a result of the proportionate approach to technology appraisals work done between April 2022 and March 2023. It should be read alongside the relevant sections of the NICE health technology evaluations manual
Show all sections
Guide to the processes of technology appraisal
Lebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over [ID4025]
In development [GID-TA11349] Expected publication date: TBC
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
In development [GID-TA11096] Expected publication date: 24 July 2024
In development [GID-TA10928] Expected publication date: 16 October 2024
How voluntary and community sector (VCS) organisations can help us develop guidance
Support for organisations who contribute to developing our guidance
NICE priority methodological research areas.
Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015]
In development [GID-TA11250] Expected publication date: TBC
An outline of the roles and responsibilities of the National Institute for Health and Care Excellence
take part in the appraisal and to nominate clinical, commissioning and patient experts . We ask consultees to submit any relevant...
Medical technologies evaluation programme process guide (PMG34)
Medical technologies evaluation programme process guide
Show all sections
- 1 Introduction
- 2 The medical technologies evaluation programme
- 3 Who is involved in the medical technologies evaluation programme
- 4 Identifying, selecting and routing technologies for evaluation
- 5 How medical technologies guidance is developed
- 6 Resolution
- 7 Publishing medical technologies guidance
- 8 Reviews
In development [GID-TA11174] Expected publication date: 16 October 2024
Vamorolone for treating Duchenne muscular dystrophy [ID4024]
In development [GID-TA11135] Expected publication date: TBC
NHS, local government, social care, patients and their families. Responsible for: clinical guidelines public health...
This guideline covers oral health, including dental health and daily mouth care, for adults in care homes. The aim is to maintain and improve their oral health and ensure timely access to dental treatment.
Ruxolitinib for treating non-segmental vitiligo in people 12 years and over [ID3998]
In development [GID-TA10893] Expected publication date: 31 July 2024
This guideline covers safe and effective use of medicines in health and social care for people taking 1 or more medicines. It aims to ensure that medicines provide the greatest possible benefit to people by encouraging medicines reconciliation, medication review, and the use of patient decision aids.
the NHS or public health service in the UK someone with experience in representing patients or carers, or who is a...
Awaiting development [GID-DG10087] Expected publication date: TBC
Find out more about the types of organisations that can register to be a stakeholder at NICE.
Efgartigimod for treating generalised myasthenia gravis [ID4003]
In development [GID-TA10986] Expected publication date: 24 July 2024
This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.
Biographies and registered interests for members of the Technology Appraisal Committee A
The section of the NICE impact lung cancer report looking at how lung cancer is detected.
Neuroendocrine tumours (metastatic, unresectable, progressive) - everolimus and sunitinib [ID858]
In development [GID-TA10024] Expected publication date: 28 June 2017
This quality standard covers sexual health, focusing on preventing sexually transmitted infections (STIs). It describes high-quality care in priority areas for improvement.
View quality statements for QS178Show all sections
Sections for QS178
- Quality statements
- Quality statement 1: Asking people about their sexual history
- Quality statement 2: Discussing prevention and testing with people who are at risk of sexually transmitted infections
- Quality statement 3: Condom distribution schemes
- Quality statement 4: Access to sexual health services
- Quality statement 5: Repeat testing for sexually transmitted infections
- Quality statement 6: Partner notification
- Update information
Dyspepsia and gastro‑oesophageal reflux disease in adults (QS96)
This quality standard covers investigating and managing symptoms of dyspepsia (indigestion) and gastro-oesophageal reflux disease (heartburn or reflux) in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
View quality statements for QS96Show all sections
Sections for QS96
- Quality statements
- Quality statement 1: Advice to support self-management
- Quality statement 2: Urgent endoscopy
- Quality statement 3: Testing conditions for Helicobacter pylori
- Quality statement 4: Discussion about referral for non-urgent endoscopy
- Quality statement 5: Referral to a specialist service
- Update information
- About this quality standard
In development [GID-TA10655] Expected publication date: TBC
Interventional procedures programme manual
Find out more about quality standards advisory committee 2 members at NICE
In development [GID-TA10985] Expected publication date: 12 June 2024
Oesophago-gastric cancer: assessment and management in adults (NG83)
This guideline covers assessing and managing oesophago-gastric cancer in adults, including radical and palliative treatment and nutritional support. It aims to reduce variation in practice through better organisation of care and support, and improve quality of life and survival by giving advice on the most suitable treatments depending on cancer type, stage and location.
OASIS Group: improving quality of life in patients with lower limb Osteoarthritis
group has confirmed an improvement in functional outcomes in over 70% of patients, over 60% reported reduced pain levels and the DNA...
Support for voluntary and community sector organisations using NICE guidance
A step-by-step timeline of the process we used to develop single technology appraisals (STA)
Learn from NICE International, part of the UK’s National Institute for Health and Care Excellence, about how to improve your nation’s health and wellbeing
This guide describes the process NICE uses to develop indicators from NICE quality standards, NICE guidance and NICE accredited sources
This guideline covers the care and support of adults receiving social care in their own homes, residential care and community settings. It aims to help people understand what care they can expect and to improve their experience by supporting them to make decisions about their care.
View recommendations for NG86Show all sections
Integrated health and social care for people experiencing homelessness (NG214)
This guideline covers providing integrated health and social care services for people experiencing homelessness. It aims to improve access to and engagement with health and social care, and ensure care is coordinated across different services.
This quality standard covers managing medicines safely and effectively in care homes. It includes processes for prescribing, handling and administering medicines for adults, young people, and children living in care homes. It also includes providing care and support relating to medicines. It describes high-quality care in priority areas for improvement.
View quality statements for QS85Show all sections
Sections for QS85
Abaloparatide for treating osteoporosis in postmenopausal women [ID882]
In development [GID-TA10071] Expected publication date: TBC
Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia
Awaiting development [GID-MT599] Expected publication date: TBC
This guideline covers the assessment for and management of blood transfusions in adults, young people and children over 1 year old. It covers the general principles of blood transfusion, but does not make recommendations relating to specific conditions.
This quality standard covers preventing and treating surgical site infections. It covers adults, young people and children having a surgical procedure that involves a cut to the skin in all healthcare settings. It describes high-quality care in priority areas for improvement.
View quality statements for QS49Show all sections
Sections for QS49
- Quality statements
- Quality statement 1: Personal preparation for surgery
- Quality statement 2: Antibiotic prophylaxis
- Quality statement 3: Patient temperature
- Quality statement 4: Intraoperative staff practices
- Quality statement 5: Information and advice on wound care
- Quality statement 6: Treatment of surgical site infection
- Quality statement 7: Surveillance
things like: making a cut or a hole to gain access to the inside of a patient's body, for example an operation or inserting a tube into...
In development [GID-TA11289] Expected publication date: TBC